Global Nasal Spray Market Industry Analysis, Trends, Size, 2017 To 2024
Global Nasal Spray Market, By Type (Decongestant nasal spray, salt water solution/ saline nasal spray, steroid nasal spray), By Container Design (Pressurized Canisters, Pump Bottles), By Dosage form (Unit/Single dose, Bi-dose, multi-dose), By Prescription (Prescribed, Over-the-counter), By Therapeutic Class (Antihistamine, Nasal Steroids, Mast Cell Inhibitor, Anticholinergic), By Application (Allergic and non-allergic Rhinitis, Nasal Congestion, CNS disorders, Vaccination, Others), End User (Hospital, ASC/Clinics, Home Care Setting, Pharmacy, Others), By Geography (North America, Europe, Asia-Pacific, South America, Middle East & Africa) – Industry Trends and Forecast to 2024
Global Nasal Spray Market is expected to reach USD 19.4 billion by 2024 from USD 11.9 billion in 2016, at a CAGR of 6.3% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Request for Sample Report Visit @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-nasal-spray-market
Some of the major companies operating in this market are:
• Sandoz International,Catalent
• Pfizer
• AptarGroup, Inc.
• Nastech pharmaceutical
• Adapt Pharma, Inc.
• Mylan N.V
• Innovus pharmaceuticals
• Allergan PLC
• Nephron pharmaceutical corporation
• Cipla ltd.
• Meda pharmaceuticals, Inc.
• Sunovion pharmaceuticals
• Teva respiratory, Llc.
• Apotexcorp
• Novartis
• Valent pharmaceuticals international, Inc.
The global nasal spray market is segmented on the basis of product type, container design, dosage form, prescription/availability, therapeutic class, application, and end-user. On the basis of product type the global nasal spray market is segmented into decongestion nasal spray, salt water solution/ saline nasal spray, and steroid nasal spray. On the basis of end-user the global nasal spray market is segmented into hospitals, clinics, home care settings, pharmacies, and community health care.
Based on geography the global nasal spray market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa. The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others. In 2017, North America is expected to dominate the nasal spray market with 52.1% market share followed by Europe and APAC.
The global nasal spray market is highly fragmented with various companies operating in local regions. The major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. Some of the examples for these strategies are: In October 2016, Adapt Pharma received Health Canada approval for its naloxone hydrochloride nasal spray which is used for the treatment of opioid overdose. The report includes company share data for different geographies including Global, North America, Europe and APAC.
Read more about the Global Nasal Spray Market Visit @ http://databridgemarketresearch.com/reports/pharmaceutical/global-nasal-spray-market/
Table of Content:
1. INTRODUCTION
1.1. OVERVIEW OF THE GLOBAL NASAL SPRAY MARKET
1.2. MARKET SEGMENTATION & COVERAGE
1.2.1. CURRENCY AND PRICING
1.2.2. LIMITATION
1.2.3. STAKEHOLDERS
2. RESEARCH METHODOLOGY
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE GLOBAL NASAL SPRAY MARKET SIZE
2.2.1. MARKET CRACKDOWN APPROACH
2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
2.2.3. DATA TRIANGULATION
2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES
2.2.6. PORTER’S FIVE FORCES MATRIX
2.3. GLOBAL NASAL SPRAY MARKET: RESEARCH SNAPSHOT
2.4. ASSUMPTIONS
3. MARKET LANDSCAPE SUMMARY
4. PREMIUM INSIGHTS
4.1. OVERVIEW
4.2. GLOBAL NASAL SPRAY MARKET: KEY PRIMARY INSIGHTS
4.3. MARKET OVERVIEW
4.3.1. DRIVERS
4.3.1.1. IMPROVING PATIENT COMPLIANCE AND ACCEPTIBILITY
4.3.1.2. EFFECTIVENESS OVER OTHER FORMS OF DRUG DELIVERY
4.3.2. RESTRAINTS
4.3.2.1. DRUG FAILURES
4.3.2.2. COMPLIANCE OF INHALING NASAL SPRAYS
4.3.3. OPPURTUNITIES
4.3.3.1. RISING DEMAND FOR SELF ADMINISTRATIVE DRUG DELIVERY
4.3.3.2. EXPANDING THERAPEUTIC APPLICATIONS FOR NASAL SPRAYS
4.3.4. THREATS
4.3.4.1. PRODUCT RECALLS
4.3.4.2. REGULATORY HURDLES
4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES
5. NASAL SPRAY MARKET, BY PRODUCT TYPE
5.1. OVERVIEW
5.2. DECONGESTION NASAL SPRAY
5.3. SALT WATER SOLUTION/ SALINE NASAL SPRAY
5.4. STEROID NASAL SPRAY
6. NASAL SPRAY MARKET, BY CONTAINER DESIGN
6.1. OVERVIEW
6.2. PRESSURIZED CANISTERS
6.3. PUMP BOTTLES
7. NASAL SPRAY MARKET, BY DOSAGE FORM
7.1. OVERVIEW
7.2. UNIT/SINGLE DOSE
7.3. BI DOSE
7.4. MULTI DOSE
8. NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY
8.1. OVERVIEW
8.2. PRESCRIBED
8.3. OVER THE COUNTER
9. NASAL SPRAY MARKET, BY THERAPEUTIC CLASS
9.1. OVERVIEW
9.2. ANTIHISTAMINE
9.3. NASAL STEROIDS
9.4. MAST CELL INHIBITOR
9.5. ANTICHOLINERGIC
10. NASAL SPRAY MARKET, BY APPLICATION
10.1. OVERVIEW
10.2. ALLERGIC AND NON-ALLERGIC RHINITIS
10.3. NASAL CONGESTION
10.4. CENTRAL NERVOUS SYSTEM DISORDERS
10.5. VACCINATION
10.6. OTHERS
11. NASAL SPRAY MARKET, BY END USER
11.1. OVERVIEW
11.2. HOSPITALS
11.3. CLINICS
11.4. HOME CARE SETTINGS
11.5. PHARMACIES
11.6. COMMUNITY HEALTH CARE
12. NASAL SPRAY MARKET, BY GEOGRAPHY
12.1. COUNTRYWISE NASAL SPRAY MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
12.1.1. NORTH AMERICA
12.1.1.1. U.S.
12.1.1.2. CANADA
12.1.1.3. MEXICO
12.1.2. EUROPE
12.1.2.1. GERMANY
12.1.2.2. FRANCE
12.1.2.3. U.K.
12.1.2.4. ITALY
12.1.2.5. SPAIN
12.1.2.6. RUSSIA
12.1.2.7. TURKEY
12.1.2.8. BELGIUM
12.1.2.12. NETHERLANDS
12.1.2.13. SWITZERLAND
12.1.2.14. REST OF EUROPE
12.1.3. ASIA-PACIFIC (APAC)
12.1.3.1. JAPAN
12.1.3.2. CHINA
12.1.3.3. SOUTH KOREA
12.1.3.4. INDIA
12.1.3.5. AUSTRALIA
12.1.3.6. SINGAPORE
12.1.3.7. THAILAND
12.1.3.8. MALAYSIA
12.1.3.12. INDONESIA
12.1.3.13. PHILIPPINES
12.1.3.14. REST OF APAC
12.1.4. LATIN AMERICA
12.1.4.1. BRAZIL
12.1.4.2. REST OF LATIN AMERICA
12.1.5. MIDDLE EAST AND AFRICA
12.1.5.1. SOUTH AFRICA
12.1.5.2. REST OF MIDDLE EAST AND AFRICA
12.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
13. NASAL SPRAY MARKET: COMPETITIVE LANDSCAPE
13.1. GLOBAL NASAL SPRAY MARKET: COMPANY SHARE ANALYSIS
13.2. U.S. NASAL SPRAY MARKET: COMPANY SHARE ANALYSIS
13.3. EUROPE NASAL SPRAY MARKET: COMPANY SHARE ANALYSIS
13.4. APAC NASAL SPRAY MARKET: COMPANY SHARE ANALYSIS
13.5. SOUTH AMERICA NASAL SPRAY MARKET: COMPANY SHARE ANALYSIS
13.6. MIDDLE EAST AND AFRICA NASAL SPRAY MARKET: COMPANY SHARE ANALYSIS
13.7. MERGERS & ACQUISITIONS
13.8. NEW PRODUCT DEVELOPMENT & APPROVALS
13.9. EXPANSIONS
13.10. REGULATORY CHANGES
13.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
14. NASAL SPRAY MARKET, COMPANY PROFILES
14.1. SANDOZ INTERNATIONAL
14.2. CATALENT
14.3. PFIZER, INC.
14.4. PFEIFFER GMBH
14.5. NASTECH PHARMACEUTICAL
14.6. ADAPT PHARMA, INC.
14.7. MYLAN
14.8. INNOVUS PHARMACEUTICALS
14.9. ALLERGAN PLC
14.10. NEPHRON PHARMACEUTICALS CORPORATION
14.11. CIPLA LTD
14.12. MEDA PHARMACEUTICALS, INC.
14.13. SUNOVION PHARMACEUTICALS INC.
14.14. TEVA RESPIRATORY, LLC.
14.15. APOTEX CORP.
15. APPENDIX
15.1. RELATED REPORTS
15.2. CUSTOMIZABLE OPTIONS
15.3. SOURCE SHEET
Inquiry before Buying Visit @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-nasal-spray-market
Related Report
Global Radiopharmaceuticals Market – Industry Trends and Forecast to 2024
Global Radiopharmaceuticals Market, By Type (Diagnostic, Therapeutic), Procedural Volumes (Diagnostic Procedures, Therapeutic Procedures), Application, Sources (Nuclear Reactors, Cyclotrons), End User, Geography (North America, Europe, APAC, South America, MEA)– Industry Trends andForecast To 2024
Report Access: http://databridgemarketresearch.com/reports/pharmaceutical/global-radiopharmaceuticals-market-trends-forecast-2024/
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Ankit Singh
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sales@databridgemarketresearch.com
Investor: investors@databridgemarketresearch.com
Visit Blog: http://databridgemarketresearch.com/blog/
Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research